机构地区:[1]新疆医科大学第一附属医院血液病中心实验室,新疆维吾尔自治区血液病研究所,乌鲁木齐830054
出 处:《临床血液学杂志》2024年第3期183-189,195,共8页Journal of Clinical Hematology
基 金:新疆维吾尔自治区自然科学基金青年项目(No:2022D01C754)。
摘 要:目的:探讨TIGIT、CD226、CD96和CD155在血小板糖蛋白自身抗体(platelet glycoprotein autoantibody,GPs)阳性的原发性免疫性血小板减少症(immune thrombocytopenia,ITP)患者外周血CD8^(+)T细胞和树突状细胞(dendritic cell,DC)膜表面的表达,并分析其临床意义。方法:选取41例GPs阳性的ITP患者和20例健康对照者,采用流式细胞术检测CD8^(+)T细胞表面TIGIT、CD226和CD96表达比例,并检测ITP患者外周血DC细胞的亚群变化及浆细胞样DC(plasma DC,pDC)上CD155的表达比例。结果:GPs阳性ITP组患者的pDC和CD155^(+)pDC比例均明显高于对照组,且GPⅠb/Ⅸ^(+)/Ⅱb/Ⅲa^(+/-)组均明显高于GPⅠb/Ⅸ^(-)/Ⅱb/Ⅲa^(+)组(P<0.05,F=40.83;P<0.01,F=59.50)。GPs阳性ITP组患者的TIGIT+CD8^(+)T细胞比例明显低于对照组,且GPⅠb/Ⅸ^(+)/Ⅱb/Ⅲa^(+/-)组明显低于GPⅠb/Ⅸ^(-)/Ⅱb/Ⅲa^(+)组(P<0.05,F=36.41),但CD226^(+)CD8^(+)T细胞与CD96^(+)CD8^(+)T细胞比例均明显高于对照组,且GPⅠb/Ⅸ^(+)/Ⅱb/Ⅲa^(+/-)组均明显高于GPⅠb/Ⅸ^(-)/Ⅱb/Ⅲa^(+)组(P<0.05,F=45.01;P<0.01,F=41.66)。GPⅠb/Ⅸ^(-)/Ⅱb/Ⅲa^(+)组与GPⅠb/Ⅸ^(+)/Ⅱb/Ⅲa^(+/-)组的CD155^(+)pDC与TIGIT+CD8^(+)T细胞比例呈负相关(P<0.01,r=-0.54;P<0.01,r=-0.76),与CD226^(+)CD8^(+)T细胞和CD96^(+)CD8^(+)T细胞比例呈正相关(P<0.05,r=0.61;P<0.05,r=0.51;P<0.01,r=0.79;P<0.01,r=0.73)。结论:TIGIT、CD226、CD96与CD155表达异常,导致GPs阳性的ITP的免疫失耐受,可能参与了疾病发生。Objective: To investigate the expression of TIGIT,CD226,CD96 and CD155 on CD8^(+)T cells and dendritic cells(DC)in the peripheral blood of patients with platelet glycoprotein autoantibody(GPs)-positive primary immune thrombocytopenia(ITP)and to analyze their clinical significance.Methods: Forty-one GP-positive ITP patients and 20 healthy individuals were selected.The flow cytometry was used to detect the percentage of TIGIT,CD226,and CD96 expression on CD8^(+)T cells and the changes in DC cell subsets and the percentage of CD155 expression on plasma DC(pDC)were analyzed.Results:The percentage of pDC and CD155^(+)pDC in the GPs-positive ITP group were significantly higher than those in the healthy control group,and they were significantly higher in the GPⅠb/Ⅸ^(+)/Ⅱb/Ⅲa^(+/-)group than those in the GPⅠb/Ⅸ^(-)/Ⅱb/Ⅲa^(+)group(P<0.05,F=40.83;P<0.01,F=59.50).On the other hand,the percentage of TIGIT+CD8^(+)T cells in the GPs-positive ITP group was significantly lower than that in the healthy control group,and it was significantly lower in the GPⅠb/Ⅸ^(+)/Ⅱb/Ⅲa^(+/-)group than that in the GPⅠb/Ⅸ^(-)/Ⅱb/Ⅲa^(+)group(P<0.05,F=36.41).However,the percentages of CD226^(+)CD8^(+)T cells and CD96^(+)CD8^(+)T cells were significantly higher than those in the control group,and they were significantly higher in the GPⅠb/Ⅸ^(+)/Ⅱb/Ⅲa^(+/-)group than those in the GPⅠb/Ⅸ^(-)/Ⅱb/Ⅲa^(+)group(P<0.05,F=45.01;P<0.01,F=41.66).The percentages of CD155^(+)pDC in the GPⅠb/Ⅸ^(-)/Ⅱb/Ⅲa^(+)group and GPⅠb/Ⅸ^(+)/Ⅱb/Ⅲa^(+/-)group were negatively correlated with TIGIT+CD8^(+)T cells(P<0.01,r=-0.54;P<0.01,r=-0.76),while it positively correlated with the percentages of CD226^(+)CD8^(+)T cells and CD96^(+)CD8^(+)T cells(P<0.05,r=0.61;P<0.05,r=0.51;P<0.01,r=0.79;P<0.01,r=0.73).Conclusion: The abnormal expression of TIGIT,CD226,CD96,and CD155 contributes to immune intolerance in GPs-positive ITP,which may be involved in the pathogenesis of the disease.
关 键 词:免疫性血小板减少症 抑制性分子 CD226 CD96
分 类 号:R558.2[医药卫生—血液循环系统疾病]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...